CSOP INVESTMENTS III VCC (SUN)
General Announcement: Net Asset Value per unit
General Announcement: Net Asset Value per unit
General Announcement: Net Asset Value per unit
COURTOIS SA : Variation droits de vote 07/2026
NYSE Content Update: Pinnacle Acquisition + Ticketplus to Debut for Trade
Other Report or Announcement
Other Report or Announcement
General Announcement: THE PROPOSED ENTRY INTO A WAREHOUSING AND LOGISTICS COOPERATION AS AN INTERESTED PERSON TRANSACTION
Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Clinical trial NCT07291232 updates: 1. completion date: 2026-10-01 → 2027-03-01 2. primary completion date: 2026-10-01 → 2027-03-01 3. enrollment: 48 → 80 participants
Clinical trial NCT04689828: completion date: 2026-09-30 → 2026-09-10.